{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:26:46Z","timestamp":1795019206317,"version":"4.10.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["22-0402"],"award-info":[{"award-number":["22-0402"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011713","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["22-0402"],"award-info":[{"award-number":["22-0402"]}],"id":[{"id":"10.13039\/100011713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 26406"],"award-info":[{"award-number":["IG 26406"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["StartUp Grant 21474"],"award-info":[{"award-number":["StartUp Grant 21474"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fondazione IEO-CCM and Credit Agricole","id":[{"id":"https:\/\/ror.org\/02yjmtx54","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004710","name":"Fondazione Umberto Veronesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["860715"],"award-info":[{"award-number":["860715"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["860715"],"award-info":[{"award-number":["860715"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["860715"],"award-info":[{"award-number":["860715"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-024-01318-z","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T05:03:56Z","timestamp":1739336636000},"page":"967-984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1934-9644","authenticated-orcid":false,"given":"Mattia","family":"Ballerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Gali\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punit","family":"Tyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Catozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariam","family":"Raji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3276-1368","authenticated-orcid":false,"given":"Amir","family":"Nabinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeli D. G.","family":"Macandog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cordiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca Ionela","family":"Slivinschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol K.","family":"Kugiejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Freisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5758-2019","authenticated-orcid":false,"given":"Paola","family":"Occhetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Wargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier F.","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cocorocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1583-5794","authenticated-orcid":false,"given":"Nicola","family":"Segata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vignati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey","family":"Morgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Deleidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8552-3625","authenticated-orcid":false,"given":"Teresa","family":"Manzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-8652","authenticated-orcid":false,"given":"Marco","family":"Rasponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4670-7656","authenticated-orcid":false,"given":"Luigi","family":"Nezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"1318_CR1","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/jamaoncol.2015.1184","volume":"1","author":"J Larkin","year":"2015","unstructured":"Larkin, J. et al. Efficacy and safety of nivolumab in patients with BRAF V600 mutant and BRAF wild-type advanced melanoma: a pooled analysis of 4 clinical trials. JAMA Oncol. 1, 433\u2013440 (2015).","journal-title":"JAMA Oncol."},{"key":"1318_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","volume":"33","author":"D Schadendorf","year":"2015","unstructured":"Schadendorf, D. et al. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma. J. Clin. Oncol. 33, 1889\u20131894 (2015).","journal-title":"J. Clin. Oncol."},{"key":"1318_CR3","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2016.4059","volume":"315","author":"A Ribas","year":"2016","unstructured":"Ribas, A. et al. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. JAMA 315, 1600\u20131609 (2016).","journal-title":"JAMA"},{"key":"1318_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/S1470-2045(19)30388-2","volume":"20","author":"C Robert","year":"2019","unstructured":"Robert, C. et al. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study. Lancet Oncol. 20, 1239\u20131251 (2019).","journal-title":"Lancet Oncol."},{"key":"1318_CR5","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert, C. et al. Pembrolizumab versus ipilimumab in advanced melanoma. N. Engl. J. Med. 372, 2521\u20132532 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1318_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert, C. et al. Nivolumab in previously untreated melanoma without BRAF mutation. N. Engl. J. Med. 372, 320\u2013330 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1318_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"1318_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nri.2017.112","volume":"18","author":"MN Wykes","year":"2017","unstructured":"Wykes, M. N. & Lewin, S. R. Immune checkpoint blockade in infectious diseases. Nat. Rev. Immunol. 18, 91\u2013104 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"1318_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"1318_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41571-022-00600-w","volume":"19","author":"DB Johnson","year":"2022","unstructured":"Johnson, D. B., Nebhan, C. A., Moslehi, J. J. & Balko, J. M. Immune-checkpoint inhibitors: long-term implications of toxicity. Nat. Rev. Clin. Oncol. 19, 254\u2013267 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1318_CR11","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","volume":"184","author":"G Morad","year":"2021","unstructured":"Morad, G., Helmink, B. A., Sharma, P. & Wargo, J. A. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell 184, 5309\u20135337 (2021).","journal-title":"Cell"},{"key":"1318_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"1318_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104\u2013108 (2018).","journal-title":"Science"},{"key":"1318_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91\u201397 (2018).","journal-title":"Science"},{"key":"1318_CR15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.neo.2017.08.004","volume":"19","author":"AE Frankel","year":"2017","unstructured":"Frankel, A. E. et al. Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients. Neoplasia 19, 848\u2013855 (2017).","journal-title":"Neoplasia"},{"key":"1318_CR16","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","volume":"307","author":"F B\u00e4ckhed","year":"2005","unstructured":"B\u00e4ckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A. & Gordon, J. I. Host-bacterial mutualism in the human intestine. Science 307, 1915\u20131920 (2005).","journal-title":"Science"},{"key":"1318_CR17","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1126\/science.1124234","volume":"312","author":"SR Gill","year":"2006","unstructured":"Gill, S. R. et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355\u20131359 (2006).","journal-title":"Science"},{"key":"1318_CR18","doi-asserted-by":"publisher","unstructured":"Cresci, G. A. M. & Izzo, K. in Adult Short Bowel Syndrome: Nutritional, Medical, and Surgical Management (eds Corrigan, M. L.) 45\u201354 (Academic, 2019); https:\/\/doi.org\/10.1016\/B978-0-12-814330-8.00004-4","DOI":"10.1016\/B978-0-12-814330-8.00004-4"},{"key":"1318_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.immuni.2019.08.003","volume":"51","author":"Y Litvak","year":"2019","unstructured":"Litvak, Y. & B\u00e4umler, A. J. Microbiota-nourishing immunity: a guide to understanding our microbial self. Immunity 51, 214\u2013224 (2019).","journal-title":"Immunity"},{"key":"1318_CR20","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13073-021-00921-y","volume":"13","author":"W Ma","year":"2021","unstructured":"Ma, W. et al. Dietary fiber intake, the gut microbiome, and chronic systemic inflammation in a cohort of adult men. Genome Med. 13, 102 (2021).","journal-title":"Genome Med."},{"key":"1318_CR21","doi-asserted-by":"publisher","first-page":"356589","DOI":"10.3389\/fmicb.2018.01835","volume":"9","author":"ZY Kho","year":"2018","unstructured":"Kho, Z. Y. & Lal, S. K. The human gut microbiome\u2014a potential controller of wellness and disease. Front. Microbiol. 9, 356589 (2018).","journal-title":"Front. Microbiol."},{"key":"1318_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"JM Pickard","year":"2017","unstructured":"Pickard, J. M., Zeng, M. Y., Caruso, R. & N\u00fa\u00f1ez, G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279, 70\u201389 (2017).","journal-title":"Immunol. Rev."},{"key":"1318_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41591-022-01698-2","volume":"28","author":"JA McCulloch","year":"2022","unstructured":"McCulloch, J. A. et al. Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1. Nat. Med. 28, 545\u2013556 (2022).","journal-title":"Nat. Med."},{"key":"1318_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00018-017-2693-8","volume":"75","author":"F Hugenholtz","year":"2018","unstructured":"Hugenholtz, F. & de Vos, W. M. Mouse models for human intestinal microbiota research: a critical evaluation. Cell. Mol. Life Sci. 75, 149\u2013160 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"1318_CR25","doi-asserted-by":"publisher","first-page":"204173142096531","DOI":"10.1177\/2041731420965318","volume":"11","author":"Y Xiang","year":"2020","unstructured":"Xiang, Y. et al. Gut-on-chip: recreating human intestine in vitro. J. Tissue Eng. 11, 2041731420965318 (2020).","journal-title":"J. Tissue Eng."},{"key":"1318_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1242\/dmm.017400","volume":"8","author":"TLA Nguyen","year":"2015","unstructured":"Nguyen, T. L. A., Vieira-Silva, S., Liston, A. & Raes, J. How informative is the mouse for human gut microbiota research? Dis. Model. Mech. 8, 1\u201316 (2015).","journal-title":"Dis. Model. Mech."},{"key":"1318_CR27","doi-asserted-by":"publisher","first-page":"413720","DOI":"10.3389\/fmicb.2018.02897","volume":"9","author":"R Nagpal","year":"2018","unstructured":"Nagpal, R. et al. Comparative microbiome signatures and short-chain fatty acids in mouse, rat, non-human primate, and human feces. Front. Microbiol. 9, 413720 (2018).","journal-title":"Front. Microbiol."},{"key":"1318_CR28","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1126\/science.1234852","volume":"340","author":"T Sato","year":"2013","unstructured":"Sato, T. & Clevers, H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340, 1190\u20131194 (2013).","journal-title":"Science"},{"key":"1318_CR29","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1039\/c2lc40074j","volume":"12","author":"HJ Kim","year":"2012","unstructured":"Kim, H. J., Huh, D., Hamilton, G. & Ingber, D. E. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip 12, 2165\u20132174 (2012).","journal-title":"Lab Chip"},{"key":"1318_CR30","first-page":"E7","volume":"113","author":"HJ Kim","year":"2016","unstructured":"Kim, H. J., Li, H., Collins, J. J. & Ingber, D. E. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc. Natl Acad. Sci. USA 113, E7\u2013E15 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1318_CR31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature05058","volume":"442","author":"GM Whitesides","year":"2006","unstructured":"Whitesides, G. M. The origins and the future of microfluidics. Nature 442, 368\u2013373 (2006).","journal-title":"Nature"},{"key":"1318_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.bioeng.4.112601.125916","volume":"4","author":"DJ Beebe","year":"2002","unstructured":"Beebe, D. J., Mensing, G. A. & Walker, G. M. Physics and applications of microfluidics in biology. Annu. Rev. Biomed. Eng. 4, 261\u2013286 (2002).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"1318_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nature13118","volume":"507","author":"EK Sackmann","year":"2014","unstructured":"Sackmann, E. K., Fulton, A. L. & Beebe, D. J. The present and future role of microfluidics in biomedical research. Nature 507, 181\u2013189 (2014).","journal-title":"Nature"},{"key":"1318_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.tim.2022.01.014","volume":"30","author":"S Moossavi","year":"2022","unstructured":"Moossavi, S., Arrieta, M. C., Sanati-Nezhad, A. & Bishehsari, F. Gut-on-chip for ecological and causal human gut microbiome research. Trends Microbiol. 30, 710\u2013721 (2022).","journal-title":"Trends Microbiol."},{"key":"1318_CR35","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00204-022-03234-0","volume":"96","author":"KS Nitsche","year":"2022","unstructured":"Nitsche, K. S., M\u00fcller, I., Malcomber, S., Carmichael, P. L. & Bouwmeester, H. Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review. Arch. Toxicol. 96, 711\u2013741 (2022).","journal-title":"Arch. Toxicol."},{"key":"1318_CR36","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1039\/C4LC00310A","volume":"14","author":"A Marsano","year":"2014","unstructured":"Marsano, A. et al. From chip-in-a-lab to lab-on-a-chip: towards a single handheld electronic system for multiple application-specific lab-on-a-chip (ASLOC). Lab Chip 14, 2168\u20132176 (2014).","journal-title":"Lab Chip"},{"key":"1318_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41551-019-0406-3","volume":"3","author":"P Occhetta","year":"2019","unstructured":"Occhetta, P. et al. Hyperphysiological compression of articular cartilage induces an osteoarthritic phenotype in a cartilage-on-a-chip model. Nat. Biomed. Eng. 3, 545\u2013557 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"1318_CR38","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/1523-1747.ep12613748","volume":"99","author":"EW Ades","year":"1992","unstructured":"Ades, E. W. et al. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99, 683\u2013690 (1992).","journal-title":"J. Invest. Dermatol."},{"key":"1318_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature09691","volume":"470","author":"JR Spence","year":"2011","unstructured":"Spence, J. R. et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105\u2013109 (2011).","journal-title":"Nature"},{"key":"1318_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrd.2016.245","volume":"16","author":"Y Shi","year":"2017","unstructured":"Shi, Y., Inoue, H., Wu, J. C. & Yamanaka, S. Induced pluripotent stem cell technology: a decade of progress. Nat. Rev. Drug Discov. 16, 115\u2013130 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1318_CR41","first-page":"2871","volume":"8","author":"M Kasendra","year":"2018","unstructured":"Kasendra, M. et al. Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids. Nature 8, 2871 (2018).","journal-title":"Nature"},{"key":"1318_CR42","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jcmgh.2017.12.008","volume":"5","author":"MJ Workman","year":"2018","unstructured":"Workman, M. J. et al. Enhanced utilization of induced pluripotent stem cell-derived human intestinal organoids using microengineered chips. Cell Mol. Gastroenterol. Hepatol. 5, 669\u2013677.e2 (2018).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1318_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2014.01.067","volume":"157","author":"SW Crawley","year":"2014","unstructured":"Crawley, S. W. et al. Intestinal brush border assembly driven by protocadherin-based intermicrovillar adhesion. Cell 157, 433\u2013446 (2014).","journal-title":"Cell"},{"key":"1318_CR44","first-page":"6334","volume":"50","author":"T Lesuffleur","year":"1990","unstructured":"Lesuffleur, T. et al. Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res. 50, 6334\u20136343 (1990).","journal-title":"Cancer Res."},{"key":"1318_CR45","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13059-015-0614-4","volume":"16","author":"F Sommer","year":"2015","unstructured":"Sommer, F., Nookaew, I., Sommer, N., Fogelstrand, P. & B\u00e4ckhed, F. Site-specific programming of the host epithelial transcriptome by the gut microbiota. Genome Biol. 16, 62 (2015).","journal-title":"Genome Biol."},{"key":"1318_CR46","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1136\/gutjnl-2014-308820","volume":"64","author":"A Morgun","year":"2015","unstructured":"Morgun, A. et al. Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks. Gut 64, 1732\u20131743 (2015).","journal-title":"Gut"},{"key":"1318_CR47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","volume":"350","author":"M V\u00e9tizou","year":"2015","unstructured":"V\u00e9tizou, M. et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350, 1079\u20131084 (2015).","journal-title":"Science"},{"key":"1318_CR48","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/s41591-022-01695-5","volume":"28","author":"KA Lee","year":"2022","unstructured":"Lee, K. A. et al. Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma. Nat. Med. 28, 535\u2013544 (2022).","journal-title":"Nat. Med."},{"key":"1318_CR49","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar, D. et al. Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients. Science 371, 595\u2013602 (2021).","journal-title":"Science"},{"key":"1318_CR50","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","volume":"371","author":"EN Baruch","year":"2021","unstructured":"Baruch, E. N. et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science 371, 602\u2013609 (2021).","journal-title":"Science"},{"key":"1318_CR51","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-023-02453-x","volume":"29","author":"B Routy","year":"2023","unstructured":"Routy, B. et al. Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial. Nat. Med. 29, 2121\u20132132 (2023).","journal-title":"Nat. Med."},{"key":"1318_CR52","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.amjms.2021.04.011","volume":"362","author":"DP Lin","year":"2021","unstructured":"Lin, D. P., Jin, Y. L., Hu, D. Y., Ying, S. J. & Jiang, Y. Influence of TRAIL deficiency on Th17 cells and colonic microbiota in experimental colitis mouse model. Am. J. Med Sci. 362, 188\u2013197 (2021).","journal-title":"Am. J. Med Sci."},{"key":"1318_CR53","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.3390\/ijms21093385","volume":"21","author":"X Meng","year":"2020","unstructured":"Meng, X., Zhang, J., Wu, H., Yu, D. & Fang, X. Akkermansia muciniphila aspartic protease Amuc_1434* inhibits human colorectal cancer LS174T cell viability via TRAIL-mediated apoptosis pathway. Int. J. Mol. Sci. 21, 3385 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1318_CR54","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1101\/gr.220111.116","volume":"27","author":"JM Davison","year":"2017","unstructured":"Davison, J. M. et al. Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor hepatocyte nuclear factor 4 alpha. Genome Res. 27, 1195\u20131206 (2017).","journal-title":"Genome Res."},{"key":"1318_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-020-00357-6","volume":"18","author":"JK Heppert","year":"2020","unstructured":"Heppert, J. K. et al. Transcriptional programmes underlying cellular identity and microbial responsiveness in the intestinal epithelium. Nat. Rev. Gastroenterol. Hepatol. 18, 7\u201323 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1318_CR56","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1101\/gr.165845.113","volume":"24","author":"JG Camp","year":"2014","unstructured":"Camp, J. G. et al. Microbiota modulate transcription in the intestinal epithelium without remodeling the accessible chromatin landscape. Genome Res. 24, 1504 (2014).","journal-title":"Genome Res."},{"key":"1318_CR57","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cell.2015.08.059","volume":"163","author":"N Dey","year":"2015","unstructured":"Dey, N. et al. Regulators of gut motility revealed by a gnotobiotic model of diet-microbiome interactions related to travel. Cell 163, 95\u2013107 (2015).","journal-title":"Cell"},{"key":"1318_CR58","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41568-022-00513-x","volume":"22","author":"MR Fernandes","year":"2022","unstructured":"Fernandes, M. R., Aggarwal, P., Costa, R. G. F., Cole, A. M. & Trinchieri, G. Targeting the gut microbiota for cancer therapy. Nat. Rev. Cancer 22, 703\u2013722 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"1318_CR59","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1471-2180-10-172","volume":"10","author":"T Angrisano","year":"2010","unstructured":"Angrisano, T. et al. LPS-induced IL-8 activation in human intestinal epithelial cells is accompanied by specific histone H3 acetylation and methylation changes. BMC Microbiol. 10, 172 (2010).","journal-title":"BMC Microbiol."},{"key":"1318_CR60","doi-asserted-by":"publisher","first-page":"e58496","DOI":"10.1371\/journal.pone.0058496","volume":"8","author":"TDK Herath","year":"2013","unstructured":"Herath, T. D. K. et al. Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-\u03baB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts. PLoS ONE 8, e58496 (2013).","journal-title":"PLoS ONE"},{"key":"1318_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.micpath.2009.04.015","volume":"47","author":"AB Berezow","year":"2009","unstructured":"Berezow, A. B. et al. The structurally similar, penta-acylated lipopolysaccharides of Porphyromonas gingivalis and Bacteroides elicit strikingly different innate immune responses. Microb. Pathog. 47, 68\u201377 (2009).","journal-title":"Microb. Pathog."},{"key":"1318_CR62","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijmm.2016.03.001","volume":"306","author":"A Steimle","year":"2016","unstructured":"Steimle, A., Autenrieth, I. B. & Frick, J. S. Structure and function: lipid A modifications in commensals and pathogens. Int. J. Med. Microbiol. 306, 290\u2013301 (2016).","journal-title":"Int. J. Med. Microbiol."},{"key":"1318_CR63","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1056\/NEJMoa1910437","volume":"381","author":"Z DeFilipp","year":"2019","unstructured":"DeFilipp, Z. et al. Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. N. Engl. J. Med. 381, 2043\u20132050 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1318_CR64","doi-asserted-by":"publisher","first-page":"932340","DOI":"10.1155\/2014\/932340","volume":"2014","author":"L Qin","year":"2014","unstructured":"Qin, L. et al. p120 modulates LPS-induced NF-\u03baB activation partially through RhoA in bronchial epithelial cells. BioMed. Res. Int. 2014, 932340 (2014).","journal-title":"BioMed. Res. Int."},{"key":"1318_CR65","first-page":"215","volume":"9","author":"S Sarhan","year":"1989","unstructured":"Sarhan, S., Knodgen, B. & Seiler, N. The gastrointestinal tract as polyamine source for tumor growth. Anticancer Res. 9, 215\u2013223 (1989).","journal-title":"Anticancer Res."},{"key":"1318_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cellimm.2008.06.007","volume":"254","author":"Z Pei","year":"2008","unstructured":"Pei, Z., Lin, D., Song, X., Li, H. & Yao, H. TLR4 signaling promotes the expression of VEGF and TGF\u03b21 in human prostate epithelial PC3 cells induced by lipopolysaccharide. Cell Immunol. 254, 20\u201327 (2008).","journal-title":"Cell Immunol."},{"key":"1318_CR67","doi-asserted-by":"publisher","first-page":"966","DOI":"10.4049\/jimmunol.164.2.966","volume":"164","author":"E Cario","year":"2000","unstructured":"Cario, E. et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J. Immunol. 164, 966\u2013972 (2000).","journal-title":"J. Immunol."},{"key":"1318_CR68","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4049\/jimmunol.1401595","volume":"194","author":"MF Fontana","year":"2015","unstructured":"Fontana, M. F. et al. JUNB is a key transcriptional modulator of macrophage activation. J. Immunol. 194, 177\u2013186 (2015).","journal-title":"J. Immunol."},{"key":"1318_CR69","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1053\/j.gastro.2020.06.038","volume":"159","author":"M Rawat","year":"2020","unstructured":"Rawat, M. et al. IL1B increases intestinal tight junction permeability by up-regulation of MIR200C-3p, which degrades occludin mRNA. Gastroenterology 159, 1375\u20131389 (2020).","journal-title":"Gastroenterology"},{"key":"1318_CR70","doi-asserted-by":"publisher","first-page":"2014772","DOI":"10.1080\/19490976.2021.2014772","volume":"14","author":"WJH Wu","year":"2022","unstructured":"Wu, W. J. H. et al. Interleukin-1\u03b2 secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair. Gut Microbes 14, 2014772 (2022).","journal-title":"Gut Microbes"},{"key":"1318_CR71","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.immuni.2015.03.004","volume":"42","author":"SU Seo","year":"2015","unstructured":"Seo, S. U. et al. Distinct commensals induce interleukin-1\u03b2 via NLRP3 inflammasome in inflammatory monocytes to promote intestinal inflammation in response to injury. Immunity 42, 744\u2013755 (2015).","journal-title":"Immunity"},{"key":"1318_CR72","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/mi.2010.57","volume":"4","author":"FA Carvalho","year":"2011","unstructured":"Carvalho, F. A., Aitken, J. D., Gewirtz, A. T. & Vijay-Kumar, M. TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage. Mucosal Immunol. 4, 102\u2013111 (2011).","journal-title":"Mucosal Immunol."},{"key":"1318_CR73","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1136\/gut.2011.240556","volume":"61","author":"FA Carvalho","year":"2012","unstructured":"Carvalho, F. A. et al. Interleukin-1\u03b2 (IL-1\u03b2) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis. Gut 61, 373\u2013384 (2012).","journal-title":"Gut"},{"key":"1318_CR74","doi-asserted-by":"publisher","first-page":"2031696","DOI":"10.1080\/19490976.2022.2031696","volume":"14","author":"TPM Scheithauer","year":"2022","unstructured":"Scheithauer, T. P. M. et al. Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery. Gut Microbes 14, 2031696 (2022).","journal-title":"Gut Microbes"},{"key":"1318_CR75","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41467-017-00259-3","volume":"8","author":"SJ Trietsch","year":"2017","unstructured":"Trietsch, S. J. et al. Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes. Nat. Commun. 8, 262 (2017).","journal-title":"Nat. Commun."},{"key":"1318_CR76","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1039\/D0LC00417K","volume":"20","author":"N Gjorevski","year":"2020","unstructured":"Gjorevski, N. et al. Neutrophilic infiltration in organ-on-a-chip model of tissue inflammation. Lab Chip 20, 3365\u20133374 (2020).","journal-title":"Lab Chip"},{"key":"1318_CR77","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/s41591-018-0197-1","volume":"24","author":"RN Amaria","year":"2018","unstructured":"Amaria, R. N. et al. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat. Med. 24, 1649\u20131654 (2018).","journal-title":"Nat. Med."},{"key":"1318_CR78","doi-asserted-by":"publisher","first-page":"eabq4006","DOI":"10.1126\/scitranslmed.abq4006","volume":"15","author":"TM Halsey","year":"2023","unstructured":"Halsey, T. M. et al. Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis. Sci. Transl. Med. 15, eabq4006 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1318_CR79","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/s41591-021-01406-6","volume":"27","author":"MC Andrews","year":"2021","unstructured":"Andrews, M. C. et al. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nat. Med. 27, 1432\u20131441 (2021).","journal-title":"Nat. Med."},{"key":"1318_CR80","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.chom.2021.03.003","volume":"29","author":"G Wang","year":"2021","unstructured":"Wang, G. et al. Bacteria induce skin regeneration via IL-1\u03b2 signaling. Cell Host Microbe 29, 777\u2013791.e6 (2021).","journal-title":"Cell Host Microbe"},{"key":"1318_CR81","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/mi.2014.123","volume":"8","author":"Y Jung","year":"2015","unstructured":"Jung, Y. et al. IL-1\u03b2 in eosinophil-mediated small intestinal homeostasis and IgA production. Mucosal Immunol. 8, 930\u2013942 (2015).","journal-title":"Mucosal Immunol."},{"key":"1318_CR82","doi-asserted-by":"publisher","first-page":"e21949","DOI":"10.1371\/journal.pone.0021949","volume":"6","author":"BB Ganesh","year":"2011","unstructured":"Ganesh, B. B. et al. IL-1\u03b2 promotes TGF-\u03b21 and IL-2 dependent Foxp3 expression in regulatory T cells. PLoS ONE 6, e21949 (2011).","journal-title":"PLoS ONE"},{"key":"1318_CR83","unstructured":"Andrews, S. FastQC: a quality control tool for high throughput sequence data. Babraham Bioinformatics http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ (2010)."},{"key":"1318_CR84","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"1318_CR85","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"1318_CR86","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"1318_CR87","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"1318_CR88","doi-asserted-by":"publisher","unstructured":"Wickham, H. ggplot2 (Springer, 2016); https:\/\/doi.org\/10.1007\/978-3-319-24277-4","DOI":"10.1007\/978-3-319-24277-4"},{"key":"1318_CR89","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).","journal-title":"Innovation"},{"key":"1318_CR90","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","volume":"47","author":"G Zhou","year":"2019","unstructured":"Zhou, G. et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res. 47, W234\u2013W241 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1318_CR91","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091\u20131093 (2009).","journal-title":"Bioinformatics"},{"key":"1318_CR92","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"1318_CR93","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/abio.2000.4753","volume":"285","author":"TD Schmittgen","year":"2000","unstructured":"Schmittgen, T. D. et al. Quantitative reverse transcription\u2013polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods. Anal. Biochem. 285, 194\u2013204 (2000).","journal-title":"Anal. Biochem."},{"key":"1318_CR94","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/s41587-023-01688-w","volume":"41","author":"A Blanco-M\u00edguez","year":"2023","unstructured":"Blanco-M\u00edguez, A. et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat. Biotechnol. 41, 1633\u20131644 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1318_CR95","doi-asserted-by":"crossref","unstructured":"Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife 10, e65088 (2021).","DOI":"10.7554\/eLife.65088"},{"key":"1318_CR96","unstructured":"Warnes, G. R., Bolker, B., Lumley, T. & Warnes, M. G. R. Package \u2018gtools\u2019. R Package version, 3(1) https:\/\/cran.r-project.org\/web\/packages\/gtools\/index.html (2015)."},{"key":"1318_CR97","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","volume":"1","author":"Z Gu","year":"2022","unstructured":"Gu, Z. Complex heatmap visualization. iMeta 1, e43 (2022).","journal-title":"iMeta"},{"key":"1318_CR98","unstructured":"Kassambara, A. ggpubr: \u2018ggplot2\u2019 based publication ready plots. R package version 0.6.0 https:\/\/rpkgs.datanovia.com\/ggpubr\/ (2023)."},{"key":"1318_CR99","doi-asserted-by":"publisher","unstructured":"European Institute of Oncology & Tyagi, P. Transcriptomic profile of a MECHANICALLY ACTIVE 3D GUT-ON-CHIP exposed to human FECAL MICROBIOME. Zenodo https:\/\/doi.org\/10.5281\/zenodo.13889913 (2024).","DOI":"10.5281\/zenodo.13889913"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-024-01318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-024-01318-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-024-01318-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:03:33Z","timestamp":1750269813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-024-01318-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":99,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1038\/s41551-024-01318-z","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"9 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.R. and P.O. are founders and shareholders of BiomimX Srl. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}